These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 10359727
1. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, Tsunoda R, Sakamoto T, Nakano T, Nakajima K, Ogawa H, Sugiyama S, Yoshimura M, Yasue H. Circulation; 1999 Jun 08; 99(22):2858-60. PubMed ID: 10359727 [Abstract] [Full Text] [Related]
2. Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease. Fukushima H, Kugiyama K, Sugiyama S, Honda O, Koide S, Nakamura S, Kawano H, Soejima H, Miyamoto S, Yoshimura M, Sakamoto T, Ogawa H. Am J Cardiol; 2001 Dec 15; 88(12):1370-3. PubMed ID: 11741554 [Abstract] [Full Text] [Related]
3. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, Yoshimura M, Ogawa H, Fujioka D, Kugiyama K. J Am Coll Cardiol; 2004 Jun 16; 43(12):2219-24. PubMed ID: 15193683 [Abstract] [Full Text] [Related]
4. Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL. Fujihara Y, Nakamura T, Horikoshi T, Obata JE, Fujioka D, Watanabe Y, Watanabe K, Kugiyama K. Circ J; 2019 May 24; 83(6):1302-1308. PubMed ID: 30996151 [Abstract] [Full Text] [Related]
5. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals. Nakamura T, Obata JE, Hirano M, Kitta Y, Fujioka D, Saito Y, Kawabata K, Watanabe K, Watanabe Y, Mishina H, Kugiyama K. Atherosclerosis; 2011 Sep 24; 218(1):163-7. PubMed ID: 21605862 [Abstract] [Full Text] [Related]
6. Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Nguyen SV, Nakamura T, Uematsu M, Fujioka D, Watanabe K, Watanabe Y, Obata JE, Nakamura K, Kugiyama K. J Cardiol; 2017 Mar 24; 69(3):529-535. PubMed ID: 27256217 [Abstract] [Full Text] [Related]
7. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. Steg PG, Greenlaw N, Tendera M, Tardif JC, Ferrari R, Al-Zaibag M, Dorian P, Hu D, Shalnova S, Sokn FJ, Ford I, Fox KM, Prospective Observational Longitudinal Registry of Patients With Stable Coronary Artery Disease (CLARIFY) Investigators. JAMA Intern Med; 2014 Oct 24; 174(10):1651-9. PubMed ID: 25110899 [Abstract] [Full Text] [Related]
8. High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome. Nguyen SV, Nakamura T, Kugiyama K. Circ J; 2014 Oct 24; 78(10):2492-500. PubMed ID: 25168189 [Abstract] [Full Text] [Related]
9. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsumura T, Sugiyama S, Nakano T, Nakajima K, Yasue H. Circulation; 1998 Jun 30; 97(25):2519-26. PubMed ID: 9657472 [Abstract] [Full Text] [Related]
16. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Arca M, Montali A, Valiante S, Campagna F, Pigna G, Paoletti V, Antonini R, Barillà F, Tanzilli G, Vestri A, Gaudio C. Am J Cardiol; 2007 Nov 15; 100(10):1511-6. PubMed ID: 17996510 [Abstract] [Full Text] [Related]